Omega Reports First Quarter 2026 Results and Recent Developments
Omega reported Q1 AFFO of $0.82, up from $0.75 a year ago, and raised its full-year guidance midpoint to $3.22 driven by strong investment activity. The company completed $251 million in new investments during the quarter, including real estate acquisitions and a 9.9% equity stake in Saber Healthcare.
Key figures
- Eps
- 0.47
- Guidance
- 2026 AFFO $3.19-$3.25 (prev $3.15-$3.25)
- Deal Value Usd
- 251000000
- Offering Price
- 48.08
- Shares Offered
- 2000000
- Net income
- 159000000
- Fad per share
- 0.78
- Affo per share
- 0.82
- Dividend per share
- 0.67
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.